In CBP-deficient lung cancer cells, genome-wide gene expression analysis identifies MYC as one of the top genes most significantly up-regulated by p300, and p300 is essential for CBP-deficient lung cancer cell proliferation and tumor progression in vivo74. Here, EP300 is linked to lung cancer.